Secondary malignancies among mantle cell lymphoma patients
Open Access
- 29 October 2023
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 195, 113403
Abstract
No abstract availableKeywords
Funding Information
- Cancerfonden
This publication has 30 references indexed in Scilit:
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysisAnnals of Oncology, 2016
- Modelling recurrent events: a tutorial for analysis in epidemiologyInternational Journal of Epidemiology, 2014
- Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivorsNature Reviews Clinical Oncology, 2013
- Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by BendamustinePLOS ONE, 2012
- Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma RegistryLeukemia & Lymphoma, 2011
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaBlood, 2008
- Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003International Journal of Cancer, 2007
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982
- Nonparametric Estimation of Partial Transition Probabilities in Multiple Decrement ModelsThe Annals of Statistics, 1978